Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Let's not forget..


..yes..and this has been brought up before..and how would we arrive at an equitable price??

and I bet that TPL would want a discount based on the USPTO outcomes that they were largely a part of..also, who knows how much the Germany decision impact will be money wise with regard to the MMP..

My point..very hard to place a value on our half..I would think that our senior management would only sell if the money could get a larger "bang for the buck" in the long run..too many unknowns / variables to make an informed decision by my estimation..

The value of the MMP would be very hard to project given the current enviornment (or any environment for that matter) and the mixed signals given by governing bodies..i.e. Germany vs. USPTO.



Share
New Message
Please login to post a reply